What is Curifylabs OY?
CurifyLabs OY is a Finnish healthtech innovator focused on developing advanced solutions for the automated manufacturing of personalized medicines within pharmacy and hospital settings. The company's proprietary technology streamlines the traditionally manual and time-intensive process of compounding, transforming it into an efficient, accurate, and automated system. By enabling on-demand production of tailored medications, CurifyLabs OY is poised to enhance patient care and optimize pharmaceutical operations.
How much funding has Curifylabs OY raised?
Curifylabs OY has raised a total of $10.3M across 3 funding rounds:
Grant
$2.8M
Debt
$1.1M
Other Financing Round
$6.5M
Grant (2023): $2.8M with participation from The European Innovation Council
Other Financing Round (2025): $6.5M led by Springvest
Debt (2025): $1.1M supported by Business Finland
Key Investors in Curifylabs OY
Springvest
Springvest Corporation is an investment entity focused on identifying and supporting promising projects, emphasizing entrepreneurial spirit. Their involvement suggests a strategic interest in Curifylabs OY's innovative approach to personalized medicine manufacturing.
Business Finland
Business Finland is a Finnish public organization providing innovation funding and internationalization services, aiming to boost Finland's growth. Their participation highlights support for Finnish technological advancements in the global market.
The European Innovation Council
The European Innovation Council operates within the higher education and research sector, focusing on fostering innovation. Their backing indicates a strategic alignment with Curifylabs OY's mission to advance pharmaceutical technology through innovation.
What's next for Curifylabs OY?
With the recent influx of major strategic investment and substantial enterprise-level backing, Curifylabs OY is positioned for significant scaling and market expansion. The company's focus on automating personalized medicine production aligns with growing global demand for tailored therapies. Future developments are likely to involve further technological refinement, broader adoption of their compounding solutions in healthcare institutions, and strategic partnerships to enhance their market reach. This substantial backing signals strong confidence in Curifylabs OY's potential to lead the transformation of pharmaceutical compounding.
See full Curifylabs OY company page
